Cargando…
Engineering the N-glycosylation pathway of Nicotiana tabacum for molecular pharming using CRISPR/Cas9
Molecular pharming in plants offers exciting possibilities to address global access to modern biologics. However, differences in the N-glycosylation pathway including the presence of β(1,2)-xylose and core α(1,3)-fucose can affect activity, potency and immunogenicity of plant-derived proteins. Succe...
Autores principales: | Göritzer, Kathrin, Grandits, Melanie, Grünwald-Gruber, Clemens, Figl, Rudolf, Mercx, Sébastien, Navarre, Catherine, Ma, Julian K-C., Teh, Audrey Y-H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493077/ https://www.ncbi.nlm.nih.gov/pubmed/36161010 http://dx.doi.org/10.3389/fpls.2022.1003065 |
Ejemplares similares
-
Gene Inactivation by CRISPR-Cas9 in Nicotiana tabacum BY-2 Suspension Cells
por: Mercx, Sébastien, et al.
Publicado: (2016) -
Inactivation of the β(1,2)-xylosyltransferase and the α(1,3)-fucosyltransferase genes in Nicotiana tabacum BY-2 Cells by a Multiplex CRISPR/Cas9 Strategy Results in Glycoproteins without Plant-Specific Glycans
por: Mercx, Sébastien, et al.
Publicado: (2017) -
Evolutionary and Predictive Functional Insights into the Aquaporin Gene Family in the Allotetraploid Plant Nicotiana tabacum
por: Ahmed, Jahed, et al.
Publicado: (2020) -
Nicotine‐free, nontransgenic tobacco (Nicotiana tabacum
l.) edited by CRISPR‐Cas9
por: Schachtsiek, Julia, et al.
Publicado: (2019) -
CRISPR-Cas9-Mediated Mutagenesis of the Rubisco Small Subunit Family in Nicotiana tabacum
por: Donovan, Sophie, et al.
Publicado: (2020)